Julia Wang
Director of Finance/CFO chez BEIGENE, LTD.
Fortune : 4 M $ au 31/03/2024
Postes actifs de Julia Wang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BEIGENE, LTD. | Director of Finance/CFO | 30/06/2021 | - |
| Comptroller/Controller/Auditor | 30/06/2021 | 19/03/2024 | |
| Corporate Officer/Principal | 01/06/2020 | 30/06/2021 |
Historique de carrière de Julia Wang
Anciens postes connus de Julia Wang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 | 01/01/2020 |
| QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
Formation de Julia Wang
| Shandong Normal University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Chine | 2 |
| Îles Cayman | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Health Services |
| BEIGENE, LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Julia Wang
- Expérience
